BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34448418)

  • 1. Financial Burdens of Out-of-Pocket Spending Among Medicare Fee-for-Service Beneficiaries: Role of the "Big Four" Chronic Health Conditions.
    Basu R; Liu H
    Med Care Res Rev; 2022 Aug; 79(4):576-584. PubMed ID: 34448418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
    Narang AK; Nicholas LH
    JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer.
    Davidoff AJ; Erten M; Shaffer T; Shoemaker JS; Zuckerman IH; Pandya N; Tai MH; Ke X; Stuart B
    Cancer; 2013 Mar; 119(6):1257-65. PubMed ID: 23225522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer Disease and Related Disorders and Out-of-Pocket Health Care Spending and Burden Among Elderly Medicare Beneficiaries.
    Dwibedi N; Findley PA; Wiener R C; Shen C; Sambamoorthi U
    Med Care; 2018 Mar; 56(3):240-246. PubMed ID: 29309391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-pocket health spending among Medicare beneficiaries: Which chronic diseases are most costly?
    Fong JH
    PLoS One; 2019; 14(9):e0222539. PubMed ID: 31539389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Out-of-pocket Health Care Cost Burden Among Medicare Beneficiaries With Diabetes, 1999-2017.
    Park J; Zhang P; Wang Y; Zhou X; Look KA; Bigman ET
    Diabetes Care; 2021 Aug; 44(8):1797-1804. PubMed ID: 34183427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.
    Odouard IC; Anderson GF; Alexander GC; Ballreich J
    J Manag Care Spec Pharm; 2024 Mar; 30(3):269-278. PubMed ID: 38140901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-pocket healthcare expenditures of older Americans with depression.
    Harman JS; Kelleher KJ; Reynolds CF; Pincus HA
    J Am Geriatr Soc; 2004 May; 52(5):809-13. PubMed ID: 15086667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription drug spending and hospital use among Medicare beneficiaries with heart failure.
    McGee BT; Higgins MK; Phillips V; Butler J
    Res Social Adm Pharm; 2020 Oct; 16(10):1452-1458. PubMed ID: 31953113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Income-Based Disparities in Financial Burdens of Medical Spending Under the Affordable Care Act in Families With Individuals Having Chronic Conditions.
    Xu WY; Retchin SM; Seiber EE; Li Y
    Inquiry; 2019; 56():46958019871815. PubMed ID: 31455121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Beneficiaries' High Out-of-Pocket Costs: Cost Burdens by Income and Health Status.
    Schoen C; Davis K; Willink A
    Issue Brief (Commonw Fund); 2017 May; 11():1-14. PubMed ID: 28498650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of "too much too soon".
    Doshi JA; Li P; Pettit AR; Dougherty JS; Flint A; Ladage VP
    Am J Manag Care; 2017 Mar; 23(3 Suppl):S39-S45. PubMed ID: 29648739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-pocket health care costs among older Americans.
    Crystal S; Johnson RW; Harman J; Sambamoorthi U; Kumar R
    J Gerontol B Psychol Sci Soc Sci; 2000 Jan; 55(1):S51-62. PubMed ID: 10728130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.
    Narasimmaraj PR; Oseran A; Tale A; Xu J; Essien UR; Kazi DS; Yeh RW; Wadhera RK
    J Am Coll Cardiol; 2023 Apr; 81(15):1491-1501. PubMed ID: 37045519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Expenses and Financial Hardship Among Medicare Beneficiaries With Functional Disability.
    Park S; Stimpson JP
    JAMA Netw Open; 2024 Jun; 7(6):e2417300. PubMed ID: 38884997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance.
    Parasrampuria S; Sen AP; Anderson GF
    Am J Manag Care; 2020 Sep; 26(9):388-394. PubMed ID: 32930551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Medicare Advantage Rebates Reduce Enrollees' Out-of-Pocket Spending?
    Nicholas LH; Wu S
    Med Care Res Rev; 2020 Oct; 77(5):474-482. PubMed ID: 30382801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.